18/05/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
May 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Jun »
18/05/2023
May 18, 2023, 14:56 |
Drugs
Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy
NEW: Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy showed promising activity in…
May 18, 2023, 14:47 |
Career
Academic sessions at #ESTRO23 and a great networking opportunity - Dr Bharti Devnani
Fantastic academic sessions at #ESTRO23 and a great networking opportunity . Got to present my…
May 18, 2023, 14:23 |
Blog
Today’s pharaohs of oncology should remember that! - Dr Michael Copeman
The #pyramids of Egypt were built by 1,000s of workers. The pyramids of #ASCO23 are…
May 18, 2023, 14:14 |
Opinion
How federal funding for biomedical research is critical to developing innovative treatments - Philip D Greenberg
Philip D. Greenberg, MD, FAACR, highlights how federal funding for biomedical research is critical to…
May 18, 2023, 13:57 |
Insight
Learn how to better meet the needs of older patients with cancer during ASCO23
Given increased life expectancy and the rapid pace at which the population of older adults…
All:
5
Posts:
1 - 10
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube